Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

Novartis and Artios Pharma to collaborate on DDR cancer therapies

April 7, 2021 Research and Development Novartis, RLT, oncology

Novartis and Artios Pharma have announced a global research collaboration to discover and validate next generation DNA damage response (DDR) …
News
astrazeneca_sign_sky

AstraZeneca halt paediatric trial of COVID-19 vaccine amid blood clot probe

April 7, 2021 Research and Development AstraZeneca, COVID-19, Vaccine

AstraZeneca has halted the trial of its COVID-19 vaccine on children aged between 6 and 17, while regulators investigate a …
News

NICE recommends CBT, acupuncture, and anti-depressants for chronic pain

April 7, 2021 Research and Development NICE, antidepressant, chronic pain

A new NICE guideline on the assessment and management of chronic primary pain does not recommend the prescription of painkillers, …
News
hsm_mobile_clinical_trial_istock-872676342

Real-world evidence and clinical research diversity

March 31, 2021 Research and Development rwe

Clinical trials are immensely valuable in establishing the safety and effectiveness of a drug in carefully selected participants, but what …
Feature
COVID-19 virus

Pharmafile.com’s weekly COVID-19 news round-up

March 31, 2021 Research and Development COVID-19, covid 19 news, covid-19 news, covid-19 roundup

The past week has seen plenty of positive COVID-19 news; Starpharma are to start selling their COVID-fighting nose spray in …
News

Amryt submits NDA to the FDA for Oleogel-S10

March 31, 2021 Research and Development FDA

Amryt has today announced the rolling submission of a New Drug Application (NDA) to the FDA for Olegel-S10, potential treatment …
News

EC approves combination treatment for kidney cancer

March 31, 2021 Research and Development Cancer, Europe, oncology

The European Commission (EC) has approved Ipsen’s Cabometyx in combination with Opdivo as a first-line treatment for advanced renal cell …
News

Celonic to manufacture at least 100 million CureVac COVID-19 jabs

March 31, 2021 Research and Development COVID-19, COVID-19 vaccine, CureVac, colonic, vaccine production

Celonic are to manufacture more than 100 million doses of CureVac’s COVID-19 vaccine, with 50 million shots expected to be …
News

Arecor receives £2.8m grant for rapid insulin product

March 31, 2021 Research and Development diabetes, insulin

Arecor has announced today that it has received a £2.8 million grant from Innovate UK, to support the Phase II …
News
COVID-19 virus

Pharmafile.com’s weekly COVID-19 news round-up

March 24, 2021 Research and Development COVID-19, covid 19 news, covid-19 news, news roundup

The past week has seen plenty of positive COVID-19 news; the Oxford-AstraZeneca vaccine was deemed safe and effective by the …
News

Roche’s drug cocktail reduces hospitalisation due to COVID-19 in Phase III trial

March 24, 2021 Research and Development COVID-19, Roche, covid-19 treatment

Roche’s antibody drug combination of casirivimab and imdevimab has shown to reduce hospitalisation or death by 70% in non-hospitalised patients …
News

Pfizer and Myovant’s menstrual blood loss treatment reports 78% effectiveness

March 24, 2021 Research and Development Myovant, Pfizer, Phase III trial, fibroids, uterine fibroids

Pfizer and Myovant Science’s relugolix treatment to reduce menstrual blood loss in women with uterine fibroids has shown promising results …
News

Novo Nordisk obesity treatment successful in clinical trials

March 24, 2021 Research and Development Novo Nordisk, obesity

New results from Novo Nordisk’s Phase III study on obesity saw clinically relevant weight loss, without weight regain, in people …
News

Guerbet see positive Phase III results for MRI agent

March 24, 2021 Research and Development MRI

Medical imaging company, Guerbet, have announced the success of its Phase III study into the safety and efficacy of Gadopiclenol, …
News
covid-19 virus

Pharmafile.com’s weekly COVID-19 news round-up

March 17, 2021 Research and Development COVID-19, covid-19 roundup, news roundup

The past week has seen a mix of good and bad COVID-19 news; the Oxford-AstraZeneca vaccine rollout has halted throughout …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026